July 10, 2019 - Yekaterinburg (Russia) 15.00-16.00 PANEL DISCUSSION: Manufacturing the Future in the Era of 4.0 Multiple industries are looking for novel approaches around their manufacturing strategies, from highly automated production lines to large-scale implementation of technological solutions, all…
MILANO, ITALY - July 10, 2018. The Regional Council presented the winners of the Prize 'Lombardia è Ricerca 2018'. Sponsored by Regione Lombardia, the acknowledgment gives 1 million euro to the best scientific discovery in the Life Science field, based…
Cary, N.C., and Modena, Italy, June 12, 2018 – Chiesi USA (key-A-zee), a specialty pharmaceutical company based in Cary, N.C., and the Italian biotech Holostem Terapie Avanzate S.r.l., announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug…
MODENA, ITALY - January 26, 2018 - Holostem Terapie Avanzate S.r.l. - a spin-off founded in 2008 by University of Modena and Reggio Emilia, Chiesi Farmaceutici S.p.A. and Professors Michele De Luca and Graziella Pellegrini – today announced the appointment…
MODENA, ITALY - November 8, 2017. Today, Holostem Terapie Avanzate and the University of Modena and Reggio Emilia (Unimore) have announced the publication on Nature, one of the most prestigious scientific journal, of a bio-medical study resulting from the collaboration…
MODENA, ITALY - June 2, 2017. Holostem Terapie Avanzate is founder member of the new Clust-ER "Life Sciences and Wellbeing" promoted by Emilia-Romagna Region The Clust-ER Associations are communities of public and private bodies (research centres, businesses, training bodies) that…
Parma/Modena (Italy), February 20, 2015 – The European Commission has granted a conditional marketing authorization, under Regulation (EC) No 726/2004, to Holoclar®, an advanced therapy based on autologous stem cells and capable to restore the eyesight of patients with severe cornea…
